Yellow Fever

Yellov fever is the only disease where vaccination is required before entering several countries in Africa and South America. Yellow fever vaccination is recommended before entering several countries please refer to list of countries.

Vaccination: Yellow fever vaccine is a live virus vaccine, which has been used for several decades and is effective in protecting.

Protection: A single dose confers immunity lasting 10 years or more. Adults and children over 9 months can take this vaccine. A booster dose is needed every 10 years.

Side effects: Yellow fever vaccine generally has few side effects; fewer than 5% of vaccines develop mild headache, muscle pain, or other minor symptoms 5 to 10 days after vaccination.

Yellow fever Vaccination Resource:

Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: An observational cohort study.

Arthritis Care Res (Hoboken)

Recombinant Yellow Fever Viruses Elicit CD8(+) T Cell Responses and Protective Immunity against Trypanosoma cruzi.

PLoS One

Yellow fever vaccination coverage following massive emergency immunization campaigns in rural Uganda, May 2011: a community cluster survey.

BMC Public Health

The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue.

PLoS One

Travel Characteristics and Yellow Fever Vaccine Usage Among US Global TravEpiNet Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission, 2009-2011.

Am J Trop Med Hyg

Demographic profile of sylvatic yellow fever (SYF) in Brazil from 1973 to 2008.

Trans R Soc Trop Med Hyg

Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination.

Clin Ophthalmol

[Tourism, imported parasitic diseases, and their prevention].

Med Parazitol (Mosk)

Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.

J Vaccines Vaccin

Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.

Viral Immunol

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

Vaccine

17DD yellow fever vaccine: A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.

Hum Vaccin Immunother

Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.

J Immunol

Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.

PLoS One

[Yellow fever epidemic threatens refugee camps in western Sudan].

Lakartidningen

Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009.

Rev Inst Med Trop Sao Paulo

Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review.

Am J Public Health

Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.

Clin Vaccine Immunol

Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more.

Hum Vaccin Immunother

Human endogenous retroviruses and cancer prevention: evidence and prospects.

BMC Cancer

First

Last

Jump:

To top Back to list of vaccination • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.